Preferred Label : irinotecan sucrosofate;

MeSH note : combination of irinotecan and sucrosofate;

UNII : OL741S3N8B;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.has-sante.fr/jcms/p_3633450/fr/onivyde-pegylated-liposomal-irinotecan-liposomal-pegyle-cancer-du-pancreas-metastatique
2025
false
false
false
France
irinotecan sucrosofate
treatment outcome
insurance, health, reimbursement
topoisomerase I inhibitors
antineoplastic agents
antineoplastic combined chemotherapy protocols
neoplasm metastasis
Metastatic Pancreatic Adenocarcinoma
adenocarcinoma
adult
Fluorouracil/Liposomal Irinotecan/Leucovorin/Oxaliplatin Regimen
evaluation of the transparency committee
pancreatic neoplasms
Irinotecan

---
https://www.ema.europa.eu/en/medicines/human/EPAR/onivyde-pegylated-liposomal
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Metastatic Pancreatic Adenocarcinoma
neoplasm metastasis
Pegylated Liposomal Irinotecan
Pegylated Liposomal Irinotecan
liposomes
pancreatic neoplasms
irinotecan sucrosofate
irinotecan sucrosofate
antineoplastic agents
antineoplastic agents
pregnancy
breast feeding
drug interactions
antineoplastic combined chemotherapy protocols
fluorouracil
leucovorin
Fluorouracil/Liposomal Irinotecan/Leucovorin Regimen
orphan drug production
infusions, intravenous
topoisomerase I inhibitors
topoisomerase I inhibitors
aged
DNA topoisomerases, type I
survival analysis
drug evaluation, preclinical
drug approval
europe
Irinotecan hydrochloride trihydrate (substance)
adult
adenocarcinoma
camptothecin
camptothecin
drug combinations
sucrose
sucrose
camptothecin
drug combinations
sucrose

---
http://www.has-sante.fr/portail/jcms/c_2757888/fr/onivyde
https://www.has-sante.fr/portail/jcms/c_2757888/fr/onivyde-irinotecan-liposomal-pegyle-antineoplasique
2017
false
false
false
France
French
treatment outcome
irinotecan
adult
neoplasm metastasis
pancreatic neoplasms
adenocarcinoma
Metastatic Pancreatic Adenocarcinoma
antineoplastic combined chemotherapy protocols
antineoplastic agents, phytogenic
antineoplastic agents, phytogenic
infusions, intravenous
topoisomerase I inhibitors
topoisomerase I inhibitors
evaluation of the transparency committee
fluorouracil
leucovorin
disease progression
survival analysis
guidelines for drug use
irinotecan sucrosofate
camptothecin
Irinotecan
Irinotecan

---
Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.